Intrinsic Value of S&P & Nasdaq Contact Us

Monte Rosa Therapeutics, Inc. GLUE

NASDAQ Global Select

SharesGrow Score
66/100
5/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.75
+81.4%

Monte Rosa Therapeutics, Inc. (GLUE) current share price is $17.50. The gold spot price is $4,808.10 per troy ounce. Using the formula: GLUE in gold = $17.50 × 31.1035 ÷ $4,808.10 = 0.1132 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of GLUE when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding GLUE shares over the measured period.

GLUE in US Dollars
Gold in US Dollars
GLUE in Gold (grams per share)

Real Wealth Growth Rate

GLUE
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{GLUE}_{\text{gold}}(t) = \frac{P_{\text{GLUE}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{GLUE}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{GLUE}_{\text{gold}}^{(T)}}{\text{GLUE}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{GLUE}_\text{gold}^{(0)}$ = initial gold-price, $\text{GLUE}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

KYMR
KYMR
Kymera Therapeutics, Inc.
$89.87
+1.51%
ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
NRIX
NRIX
Nurix Therapeutics, Inc.
$16.30
+2.45%
SANA
SANA
Sana Biotechnology, Inc.
$3.48
+8.41%
DSGN
DSGN
Design Therapeutics, Inc.
$12.64
+2.35%
IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
LYEL
LYEL
Lyell Immunopharma, Inc.
$23.37
-5.77%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message